Sylvester Comprehensive Cancer Center


Statins Appear to Dramatically Reduce Prostate Cancer Risk


Two cancer researchers have found that the long-term use of cholesterol-lowering statins may dramatically reduce prostate cancer risk. Rakesh Singal, M.D., an oncologist at the University of Miami Sylvester Comprehensive Cancer Center and the Miami VA Medical Center, and Vikas Khurana, M.D., from the Louisiana State University Health Sciences Center, presented their findings at the annual meeting of the American Society of Clinical Oncology in Orlando this week. “This is really quite remarkable,” said Singal. “A 90 percent reduction in prostate cancer risk in men using statins for four years or more, and the fact that the risk is decreasing with duration of statin use, that is very strong data.”